HEALTH VIDEOS
Faulty Hip Implants Leave Patients Fighting Compensation Battle
For 10 years, Vijay Vojhala, a resident of Mumbai, has not just been struggling with the aftereffects of a faulty hip implant but he has also been fighting a compensation battle. The metal-on-metal acetabular surface replacement (ASR) implant, known as DePuy ASR, was sold in India by DePuy International, a unit of J&J. Now the company in a statement has said they voluntarily recalled the implants, but doing so does not mean they are faulty. The health ministry had set up a committee under former dean of Maulana Azad Medical College Dr Arun Agarwal, which submitted a report, recommending compensation of Rs 20 lakh for patients. The committee found that the firm was evasive in providing the information and least cared about those who are living an immobile life and forced to bed. It also blamed the company for the faulty device. While a total of 4,700 surgeries were conducted in India using J&J subsidiary DePuy's ASR hip replacement system, only 1,050 implants could be traced through the ASR helpline.
More HEALTH VIDEOS
-
Prevent Obesity With These Simple Yet Effective Tips From Our Expert
2:44 -
India's Obesity Crisis: Expert Tells How To Tackle This Growing Epidemic
1:6 -
Healthy Eating For A Healthy Weight: Tips To Make Better Food Choices
4:37 -
How To Stay Active When You Have A Desk job
1:29 -
Expert Unveils The Truth Behind Obesity Myths
1:15 -
Contemplating Weight Loss Drugs? Watch This First
4:5 -
World Obesity Day 2025: What Causes Obesity? Expert Shares Insights
4:16 -
World Obesity Day: How Parents Can Help Their Children Prevent Obesity
1:46 -
How Dangerous Is HMPV: Expert Facts You Can't Miss
1:10 -
"HMPV Is Not A New Virus, There's No Need To Panic," Says Expert
1:15 -
Most Common Causes For Hair Loss In Women
4:26 -
Attack The Heart Attack - A Public Awareness Initiative By Medtronics
21:44 - 4:55
-
Managing Asthma In Children During Seasonal Changes
6:26 -
'My Health, My Right': Understanding The World Health Day 2024 Theme
3:18
